| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.42 | 0.02 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.36 | 0.02 |